LABT
Lakewood-Amedex Biotherapeutics Inc. SEC filings
Every EDGAR filing for Lakewood-Amedex Biotherapeutics Inc. (LABT), newest first, with AI summaries and stories.
- Ticker
- LABT
- CIK
- 2079272
- Latest filing
- Sep 25
Next: 10-Q expected ~May 19 (deadline May 17)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINEEFFECTLakewood-Amedex Biotherapeutics Inc.LABTLIVE NOTABLES-1Lakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINE424B3Lakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINESCHEDULE 13GLakewood-Amedex Biotherapeutics Inc.LABTLIVE Ownership stake disclosure by WFI Equity, LLC
WFI Equity, LLC, filed by
NOTABLE10-QLakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINEDEFA14ALakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINEDEF 14ALakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINESCHEDULE 13GLakewood-Amedex Biotherapeutics Inc.LABTLIVE Ownership stake disclosure by Lindesfarne LLC
Lindesfarne LLC, filed by
ROUTINEPRE 14ALakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINE8-KLakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINESCHEDULE 13GLakewood-Amedex Biotherapeutics Inc.LABTLIVE Ownership stake disclosure by HPW Investments Holding Ltd.
HPW Investments Holding Ltd., filed by
ROUTINE424B3Lakewood-Amedex Biotherapeutics Inc.LABTLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B3Securities offering
- 424B3Securities offering
ROUTINE8-KLakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINE424B3Lakewood-Amedex Biotherapeutics Inc.LABTLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B3Securities offering
- 424B3Securities offering
NOTABLE10-QLakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINE424B4Lakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINEEFFECTLakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINE4Lakewood-Amedex Biotherapeutics Inc.LABTLIVE 2 insider filings
Joseph Edward Tucker, insider filing for LABT
Show all 2
- 4Insider filing for LABT
- 3New insider at LABT
Joseph Edward Tucker, reporting
ROUTINE3Lakewood-Amedex Biotherapeutics Inc.LABTLIVE 4 insider filings
Leonard James DeRoma, new insider at LABT
Show all 4
- 3New insider at LABT
- 3New insider at LABT
- 3New insider at LABT
- 3New insider at LABT
Leonard James DeRoma, reporting
NOTABLES-1Lakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINE424B3Lakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINE8-KLakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINE424B4Lakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINECERTLakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINEEFFECTLakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINE8-A12BLakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINES-1/ALakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINES-1/ALakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINES-1/ALakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINES-1/ALakewood-Amedex Biotherapeutics Inc.LABTLIVE ROUTINES-1/ALakewood-Amedex Biotherapeutics Inc.LABTLIVE NOTABLES-1Lakewood-Amedex Biotherapeutics Inc.LIVE